Microglial Mitochondrial Dysregulation from Borrelia/Bartonella Infection
1 Myers 2009 — Microglia Mediate Borrelia-Induced Neuronal Apoptosis
Full Citation:: Myers TA, Kaushal D, Philipp MT. Microglia are mediators of Borrelia burgdorferi-induced apoptosis in SH-SY5Y neuronal cells. PLoS Pathogens. 2009;5(11):e1000659. (Myers, Kaushal, and Philipp 2009) DOI:: 10.1371/journal.ppat.1000659 PMID:: 19911057 Study Design:: In vitro co-culture (primary rhesus microglia + SH-SY5Y neuroblastoma + live Bb) Key Findings::
- Bb alone does not induce neuronal apoptosis; microglia + Bb produces robust inflammatory cytokine/chemokine expression
- Neurons + microglia + Bb → neuronal apoptosis via caspase-3
- Microglial conditioned medium sufficient (soluble mediators: TNF-α, IL-1β)
Conclusion:: Microglia are necessary intermediaries for Bb-induced neuronal injury. Limitations:: In vitro; rhesus not human microglia; cell line neurons; no mitochondrial readouts.
2 Kuhlow 2005 — Microglia as Phagocytes for Borrelia
Full Citation:: Kuhlow CJ, Garcia-Monco JC, Coleman JL, Benach JL. Murine microglia are effective phagocytes for Borrelia burgdorferi. Journal of Neuroimmunology. 2005;168(1-2):183-187. (Kuhlow et al. 2005) DOI:: 10.1016/j.jneuroim.2005.06.030 PMID:: 16125249 Study Design:: In vitro murine microglial phagocytosis assay Key Findings::
- Microglia rapidly phagocytose live Bb → proinflammatory cytokine release
- Microglial clearance may explain spirochete scarcity in CNS
Conclusion:: Microglia are first-line CNS defenders against Bb; immediate activation upon exposure. Limitations:: Murine cells; no human confirmation; no mitochondrial assays.
3 Parthasarathy 2015 — Multi-Receptor Microglial Activation by Borrelia
Full Citation:: Parthasarathy G, Philipp MT. Inflammatory mediator release from primary rhesus microglia in response to Borrelia burgdorferi results from the activation of several receptors and pathways. Journal of Neuroinflammation. 2015;12:60. (Parthasarathy and Philipp 2015) DOI:: 10.1186/s12974-015-0274-z PMID:: 25889406 Study Design:: In vitro rhesus microglia + live Bb; TLR blocking; signaling inhibitors Key Findings::
- Bb activates microglia via TLR1/TLR2/TLR5 → MyD88/TRIF → NF-κB/MAPK
- TNF-α, IL-6, IL-12, CCL2, CXCL10 all upregulated
- Multiple receptor redundancy — single-target blockade only partially effective
Conclusion:: Microglial inflammatory response to Bb is multi-receptor, multi-pathway. Limitations:: In vitro; rhesus cells; no mitochondrial readouts.
4 Cassiani-Ingoni 2006 — TLR1/TLR2 in Human Microglia
Full Citation:: Cassiani-Ingoni R, et al. Borrelia burgdorferi induces TLR1 and TLR2 in human microglia and peripheral blood monocytes but differentially regulates HLA-class II expression. Journal of Neuropathology and Experimental Neurology. 2006;65(6):540-548. (Cassiani-Ingoni et al. 2006) DOI:: 10.1097/00005072-200606000-00002 PMID:: 16783164 Study Design:: In vitro human fetal microglia, astrocytes, neurons + Bb; oligoarray gene expression Key Findings::
- Bb upregulates TLR1/TLR2 in primary human microglia (critical species translation)
- Broad transcriptional response encompassing 30+ immune genes
- Differential HLA class II regulation: microglia upregulate, PBMCs downregulate
Conclusion:: Human microglia recognize Bb through TLR1/TLR2 with a distinct transcriptional program. Limitations:: Fetal tissue; in vitro; no mitochondrial gene expression data.
5 Parthasarathy 2023 — FGF/FGFR System in Borrelia-Induced Neuroinflammation
Full Citation:: Parthasarathy G, Pattison MB, Midkiff CC. The FGF/FGFR system in the microglial neuroinflammation with Borrelia burgdorferi: likely intersectionality with other neurological conditions. Journal of Neuroinflammation. 2023;20(1):10. (Parthasarathy, Pattison, and Midkiff 2023) DOI:: 10.1186/s12974-022-02681-x PMID:: 36650549 Study Design:: In vitro rhesus microglia + Bb; RNA-seq; FGFR pathway analysis Key Findings::
- Bb upregulates FGF2 and FGFR1 in microglia
- FGFR signaling contributes to inflammatory mediator production
- Links neuroborreliosis to Alzheimer's/MS — shared neuroinflammatory pathways
Conclusion:: FGF/FGFR system is a common mechanism linking neuroborreliosis to neurodegenerative diseases. Limitations:: In vitro; rhesus; no mitochondrial analysis.
6 Xu 2023 — BmpA Protein Alone Stimulates Microglia
Full Citation:: Xu X, et al. A key protein from Borrelia burgdorferi could stimulate cytokines in human microglial cells and inhibitory effects of Cucurbitacin IIa. IBRO Neuroscience Reports. 2023;15:376-385. (Xu et al. 2023) DOI:: 10.1016/j.ibneur.2023.11.004 PMID:: 38046885 Study Design:: In vitro HMC3 human microglia + recombinant BmpA; cytokine chip + qPCR Key Findings::
- Recombinant BmpA (Bb membrane protein) alone induces IL-6, IL-8, MCP-1, GRO from microglia
- Intact spirochete not required — single protein sufficient for inflammatory response
- Cucurbitacin IIa (plant compound) inhibits cytokine production
Conclusion:: Individual Bb components can trigger microglial inflammatory response. Limitations:: HMC3 immortalized cell line; recombinant protein only; no mitochondrial data.
7 Akinlusi 2025 — Borrelia Shifts Microglia to M1 Polarization
Full Citation:: Akinlusi I, et al. Human microglia polarization following infection with the Lyme disease spirochete. Journal of Investigative Medicine. 2025;73(1):172-178. (Akinlusi et al. 2025) DOI:: 10.1177/10815589241290206 PMID:: 39324305 Study Design:: In vitro HMC3 human microglia + Bb; M1/M2 polarization markers Key Findings::
- Bb shifts microglia toward M1 (proinflammatory): iNOS, TNF-α, IL-1β upregulated
- M2 markers decreased: Arg-1, CD206
- M1 polarization would imply metabolic shift to aerobic glycolysis (not measured)
Conclusion:: Neuroborreliosis drives microglial M1 polarization, consistent with chronic neuroinflammation. Limitations:: HMC3 cell line; limited polarization markers; no metabolic/mitochondrial assays.
8 Muñana 2001 — Bartonella henselae Infects Microglia
Full Citation:: Munana KR, Vitek SM, Hegarty BC, Kordick DL, Breitschwerdt EB. Infection of fetal feline brain cells in culture with Bartonella henselae. Infection and Immunity. 2001;69(1):564-569. (Munana et al. 2001) DOI:: 10.1128/IAI.69.1.564-569.2001 PMID:: 11119554 Study Design:: In vitro feline fetal microglial- and astrocyte-enriched cultures + B. henselae Key Findings::
- B. henselae infects and survives in feline microglia and astrocytes
- Non-cytolytic persistence — bacteria survive intracellularly without immediate cell death
- Establishes Bartonella can directly invade CNS glial cells
Conclusion:: Bartonella henselae can directly infect microglia — a mechanism for CNS involvement in cat-scratch disease. Limitations:: Feline cells, not human; single study; no follow-up in human microglia; no mitochondrial or cytokine data.
9 Coughlin 2018 — In Vivo Glial Activation in PTLDS (PET Imaging)
Full Citation:: Coughlin JM, et al. Imaging glial activation in patients with post-treatment Lyme disease symptoms: a pilot study using [11C]DPA-713 PET. Journal of Neuroinflammation. 2018;15(1):346. (Coughlin et al. 2018) DOI:: 10.1186/s12974-018-1381-4 PMID:: 30567544 Study Design:: Human PET imaging; [11C]DPA-713 TSPO ligand; PTLDS vs healthy controls Sample Size:: 12 PTLDS, 19 controls Key Findings::
- Increased TSPO binding in PTLDS brains — evidence of glial activation
- Binding correlates with cognitive complaints, pain, fatigue
- Activation persists years after antibiotic treatment
Conclusion:: Glial activation is present in PTLDS patients and may drive persistent symptoms — first in vivo human evidence. Limitations:: Small n (12); TSPO cannot distinguish microglia from astrocytes; no pre-treatment baseline.
10 Parthasarathy 2022 — Non-Viable Borrelia Remnants Sustain Microglial Activation
Full Citation:: Parthasarathy G, Gadila SKG. Neuropathogenicity of non-viable Borrelia burgdorferi ex vivo. Scientific Reports. 2022;12(1):688. (Parthasarathy and Gadila 2022) DOI:: 10.1038/s41598-021-03837-0 PMID:: 35027599 Study Design:: Ex vivo comparison of viable vs antibiotic-killed Bb effects on microglia Key Findings::
- Non-viable Bb remnants still activate microglia and induce neuroinflammation
- Antibiotic treatment does not eliminate the inflammatory stimulus
- Explains persistent symptoms in PTLDS after antibiotic treatment
Conclusion:: Microbial debris suffices for sustained microglial activation — important for PTLDS/ME/CFS overlap. Limitations:: Ex vivo; mechanisms of debris recognition not fully characterized; no mitochondrial analysis.
11 Peacock 2015 — Oxidative Stress in Lyme Disease
Full Citation:: Peacock BN, et al. New insights into Lyme disease. Redox Biology. 2015;5:66-70. (Peacock et al. 2015) DOI:: 10.1016/j.redox.2015.03.002 PMID:: 25838067 Study Design:: Review + original oxidative stress data in Bb-infected cells Key Findings::
- Bb infection induces oxidative stress in multiple cell types
- Lipid peroxidation and protein carbonylation detected
- Mitochondria are primary targets of Bb-induced oxidative damage (inferred)
Conclusion:: Oxidative stress is a core pathological mechanism in Lyme disease; mitochondrial involvement likely. Limitations:: Predominantly review; limited original mitochondrial data; not microglia-specific.
12 Wawrzeniak 2020 — Borrelia Outer Membrane Vesicles Induce ROS
Full Citation:: Wawrzeniak K, et al. Effect of Borrelia burgdorferi outer membrane vesicles on host oxidative stress response. Antibiotics. 2020;9(5):275. (Wawrzeniak et al. 2020) DOI:: 10.3390/antibiotics9050275 PMID:: 32466166 Study Design:: In vitro BE2C neuroblastoma + Bb outer membrane vesicles Key Findings::
- Bb OMVs induce oxidative stress in neuronal cells (ROS production)
- OMV lipoproteins, DNA, RNA sufficient to trigger host stress responses
- Antioxidant gene expression altered
Conclusion:: Bb-derived OMVs are vehicles for host cell oxidative damage with mitochondrial implications. Limitations:: Neuroblastoma cell line, not microglia; no direct mitochondrial function assays.
13 Tsilioni 2022 — ME/CFS Exosomal mtDNA Activates Microglia
Full Citation:: Tsilioni I, Natelson B, Theoharides TC. Exosome-associated mitochondrial DNA from patients with myalgic encephalomyelitis/chronic fatigue syndrome stimulates human microglia to release IL-1β. European Journal of Neuroscience. 2022;56(10):5784-5794. (Tsilioni, Natelson, and Theoharides 2022) DOI:: 10.1111/ejn.15828 PMID:: 36153118 Study Design:: In vitro HMC3 microglia + serum exosomes from ME/CFS patients; mtDNA quantification Key Findings::
- ME/CFS serum exosomes contain elevated mtDNA (post-exercise) vs healthy controls
- ME/CFS exosomes activate HMC3 microglia to release IL-1β
- DNase treatment blocks activation → mtDNA is the active moiety
Conclusion:: Exercise-induced exosomal mtDNA release in ME/CFS directly activates microglia — bridges mitochondrial dysfunction to neuroinflammation. Limitations:: HMC3 cell line; small n (~20 ME/CFS, ~10 controls); post-exercise only; no subtyping.
15 Hirsch 2025 — GWAS Overlap Between PTLDS and ME/CFS
Full Citation:: Hirsch AG, et al. A comparison of genome-wide association analyses of persistent symptoms after Lyme disease, fibromyalgia, and myalgic encephalomyelitis — chronic fatigue syndrome. BMC Infectious Diseases. 2025;25(1):265. (Hirsch et al. 2025) DOI:: 10.1186/s12879-024-10238-x PMID:: 39994562 Study Design:: GWAS comparing PTLDS, FM, and ME/CFS Key Findings::
- No genome-wide significant loci for PTLDS (underpowered, ~200 cases)
- Suggestive genetic overlap between PTLDS, FM, and ME/CFS
- Shared pathways include immune function and neuroinflammation
Conclusion:: Tentative genetic evidence linking PTLDS to ME/CFS — supports shared neuroinflammatory susceptibility. Limitations:: Underpowered for PTLDS; no microglia-specific or mitochondrial genes at genome-wide significance.